|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
|
|
Washington, DC 20549
|
|
______________________
|
|
FORM 8-K
|
|
CURRENT REPORT PURSUANT
|
|
TO SECTION 13 OR 15(D) OF THE
|
|
SECURITIES EXCHANGE ACT OF 1934
|
|
July 12, 2012
|
|
Date of Report (Date of earliest event reported)
|
|
BOVIE MEDICAL CORPORATION
|
|
(Exact name of registrant as specified in its Charter)
|
|
Delaware
|
012183
|
11-2644611
|
||
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
734 Walt Whitman Road, Melville, New York 11747
|
|
(Address of principal executive offices) (Zip Code)
|
|
(631) 421-5452
|
|
Registrant's telephone number, including area code
|
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.07 Submission of Matters to a Vote of Security Holders
On July 12, 2012, Bovie Medical Corporation (the “Company”) held its annual meeting of stockholders. The Company’s stockholders (a) elected each of the following seven directors to serve on the Company’s Board of Directors, (b) approved the 2012 Share Incentive Plan and (c) ratified the appointment of Kingery & Crouse, P.A., as the Company’s independent auditors for the year ended December 31, 2012, by the following vote:
(a) Election of Directors
|
Name of Director
|
For
|
Withheld
|
Abstain
|
|
Andrew Makrides
|
8,547,474
|
806,041
|
500
|
|
J. Robert Saron
|
8,621,550
|
731,965
|
500
|
|
George Kromer
|
8,527,993
|
825,522
|
500
|
|
Michael Norman
|
8,594,177
|
759,296
|
542
|
|
August Lentricchia
|
8,616,458
|
737,015
|
542
|
|
Michael Geraghty
|
8,621,500
|
732,015
|
500
|
|
Lawrence J. Waldman
|
8,621,500
|
732,015
|
500
|
|
(b)
|
Approval of 2012 Share Incentive Plan.
|
|
For
|
Against
|
Abstain
|
|
7,471,354
|
1,861,926
|
20,735
|
|
(c)
|
Ratification of Kingery & Crouse, P.A. as the Company’s independent auditors for the year ended December 31, 1012.
|
|
For
|
Against
|
Abstain
|
|
14,803,724
|
482,117
|
227,993
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: July 13, 2012
|
BOVIE MEDICAL CORPORATION
|
|
|
By: /s/ Andrew Makrides
|
||
|
Andrew Makrides
|
||
|
Chief Executive Officer and
Chairman of the Board
|
3